RISING PHARMA HOLDINGS, INC. Metoprolol Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Metoprolol from India and how much does RISING PHARMA HOLDINGS, INC. import?

India exports Metoprolol to 949 buyers globally worth $96.9M. RISING PHARMA HOLDINGS, INC. imports $4.3M (0.4% market share) with 141 shipments from UNITED STATES.

Q: What is the average order value for RISING PHARMA HOLDINGS, INC.'s Metoprolol imports?

RISING PHARMA HOLDINGS, INC.'s average Metoprolol order value is $30.2K per consignment, based on 141 shipments totaling $4.3M.

Q: Who supplies Metoprolol to RISING PHARMA HOLDINGS, INC.?

RISING PHARMA HOLDINGS, INC. sources Metoprolol from 1 verified supplier: AUROBINDO PHARMA LIMITED ($4.3M, 100.0%). Based on 141 customs records.

Q: How does RISING PHARMA HOLDINGS, INC. compare to other Metoprolol importers?

RISING PHARMA HOLDINGS, INC. ranks #19 among 949 Metoprolol importers from India with 0.4% market share and 141 shipments.

Q: Who are the top Metoprolol importers from India?

Top Metoprolol importers: EVERSANA LIFE SCIENCES SERVICES LLC ($16.3M), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($12.6M), DR. REDDYS LABORATORIES, INC ($11.1M), BANCO SANT ANDER BRASIL SA ($6.5M), NORTHSTAR DISTRIBUTION CENTER 8912 ($6.3M).

Suresh Sormare

Metoprolol

India Pharmaceutical Trade Intelligence

$811.1M306 Suppliers118 CountriesHS 30049074

ExportsIndia → UNITED STATES94.0%India → BRAZIL4.6%

ImportsSWEDEN → India$4565.7B UNITED STATES → India$1.3B

#1 Supplier: RUBICON RESEARCH #1 Buyer: CIPLA USA

RISING PHARMA HOLDINGS, INC. — Metoprolol Importer #19 | $4.3M Trade Value | TransData Nexus | TransData Nexus

RISING PHARMA HOLDINGS, INC. — Metoprolol Importer Profile

Pharmaceutical Importer · #19 buyer for Metoprolol · $4.3M import value · 141 shipments · UNITED STATES · DGFT Verified

RISING PHARMA HOLDINGS, INC. is the #19 importer of Metoprolol from India with $4.3M in import value and 141 verified shipments. RISING PHARMA HOLDINGS, INC. holds a 0.4% market share in Metoprolol imports based in UNITED STATES. The company sources from 1 verified supplier across 76 formulations shipped to 1 country. Overall, RISING PHARMA HOLDINGS, INC. imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.

RISING PHARMA HOLDINGS, INC. — Metoprolol Import Profile: Suppliers, Formulations & Sources

RISING PHARMA HOLDINGS, INC. — Metoprolol import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Metoprolol to RISING PHARMA HOLDINGS, INC.?

Verified from 141 customs shipment records

Supplier	Value	Shipments	% Share
AUROBINDO PHARMA LIMITED	$4.3M	141	100.0%

RISING PHARMA HOLDINGS, INC. sources Metoprolol from 1 verified Indian supplier based on 141 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Metoprolol Importers?

Buyers ranked immediately above and below #19 by import value

#	Buyer

Where Does RISING PHARMA HOLDINGS, INC. Import Metoprolol To?

Destination countries from 141 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$4.3M	141	100.0%

RISING PHARMA HOLDINGS, INC. imports Metoprolol to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $4.3M.

What Metoprolol Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Formulation	Value	Shipments
METOPROLOL TARTRATE TABLETS 50MG (7104X	$250.0K	5
METOPROLOL TARTRATE TABLETS 50MG (METOPR	$199.3K	4
METOPROLOL TARTRATE TABLETS 25MG (44520X1000'S)NOS	$150.0K	3
METOPROLOL TARTRATE TABLETS 25MG (34748X1000'S)	$150.0K	3
METOPROLOL TARTRATE TABLETS 25MG (22200X1000'S)NOS	$146.1K	3
METOPROLOL TARTRATE TABLETS 50MG (16728X1000'S)	$141.7K	3
METOPROLOL TARTRATE TABLETS 50MG (16632X1000'S)	$137.0K	3
METOPROLOL TARTRATE TABLETS 50MG (4968X1	$132.6K	3
METOPROLOL TARTRATE TABLETS 25MG (34010	$100.0K	2
METOPROLOL TARTRATE TABLETS 50MG (18588X	$100.0K	2

RISING PHARMA HOLDINGS, INC. imports 76 distinct Metoprolol formulations from India. The top formulation is METOPROLOL TARTRATE TABLETS 50MG (7104X with 5 shipments worth $250.0K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Metoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: RISING PHARMA HOLDINGS, INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as RISING PHARMA HOLDINGS, INC.'s capped import value divided by total capped export value for Metoprolol across all Indian exporters.
5.Verified Records: This page is backed by 141 individual customs records matching RISING PHARMA HOLDINGS, INC. importing Metoprolol, covering 76 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 118+ countries, 949+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Metoprolol

Metoprolol

RISING PHARMA HOLDINGS, INC. — Metoprolol Importer Profile

RISING PHARMA HOLDINGS, INC. — Metoprolol Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Metoprolol to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Metoprolol Importers?

Where Does RISING PHARMA HOLDINGS, INC. Import Metoprolol To?

What Metoprolol Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Regulatory Requirements: Importing Metoprolol into United States

Regulatory Authority

Approval Process for Generic Metoprolol

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Metoprolol from India and How Much Does RISING PHARMA HOLDINGS, INC. Import?

What Is the Average Order Value for RISING PHARMA HOLDINGS, INC.'s Metoprolol Imports?

Who Supplies Metoprolol to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Other Metoprolol Importers?

What Other Cardiovascular Products Does RISING PHARMA HOLDINGS, INC. Import?

About RISING PHARMA HOLDINGS, INC.

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Metoprolol Import Data for RISING PHARMA HOLDINGS, INC.

RISING PHARMA HOLDINGS, INC. × Metoprolol

Company Overview

Top Products by RISING PHARMA HOLDINGS, INC.

Related Analysis

Need Detailed Import Data?

Data Source

18	PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$3.3M	76	$43.6K
16	GRANULES PHARMACEUTICALS, INC.	UNITED STATES	$3.3M	66	$50.0K
19	RISING PHARMA HOLDINGS, INC. ★	UNITED STATES	$3.1M	90	$35.0K